P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
P3 Health Partners Inc. - Class A (PIII)
Company Research
Source: Business Wire
Providing 2026 Guidance, Indicating a $10 Million Adjusted EBITDA MidpointManagement to Host Conference Call and Webcast March 26, 2026 at 4:30 PM ET HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance."2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With that work in place, we enter 2026 with a clear path to profitability and approximately $170 million of expected year-over-year EBITDA improvement at the midpoint of our guidance range," said Aric Coffman, CEO of P3. "Additionally, our new Medicare Advantage geography reflects our approach to smart growth with a deliberate glidepath toward full risk
Show less
Read more
Impact Snapshot
Event Time:
PIII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PIII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PIII alerts
High impacting P3 Health Partners Inc. - Class A news events
Weekly update
A roundup of the hottest topics
PIII
News
- P3 Health Partners (PIII) had its price target lowered by Lake Street Capital from $12.50 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- P3 Health Partners Inc (PIII) Q4 2025: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]Yahoo! Finance
- P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call [Yahoo! Finance]Yahoo! Finance
- P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference CallBusiness Wire
PIII
Earnings
- 8/14/25 - Miss
PIII
Sec Filings
- 3/26/26 - Form 10-K
- 3/26/26 - Form 8-K
- 3/25/26 - Form 8-K
- PIII's page on the SEC website